tiprankstipranks
Trending News
More News >
Naturhouse Health (GB:0R9G)
LSE:0R9G
UK Market
Advertisement

Naturhouse Health (0R9G) Ratios

Compare
1 Followers

Naturhouse Health Ratios

GB:0R9G's free cash flow for Q2 2024 was €0.71. For the 2024 fiscal year, GB:0R9G's free cash flow was decreased by € and operating cash flow was €0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.36 2.69 3.23 4.62 3.44
Quick Ratio
3.83 2.48 2.91 4.31 3.10
Cash Ratio
3.20 1.91 1.44 3.38 2.22
Solvency Ratio
0.75 0.74 0.80 1.22 0.76
Operating Cash Flow Ratio
1.79 1.64 0.85 2.01 1.50
Short-Term Operating Cash Flow Coverage
0.00 145.49 0.00 0.00 0.00
Net Current Asset Value
€ 17.27M€ 16.16M€ 12.11M€ 24.36M€ 16.89M
Leverage Ratios
Debt-to-Assets Ratio
0.07 0.10 0.08 0.05 0.09
Debt-to-Equity Ratio
0.10 0.16 0.12 0.06 0.14
Debt-to-Capital Ratio
0.09 0.14 0.11 0.06 0.12
Long-Term Debt-to-Capital Ratio
0.00 0.05 0.00 0.00 0.00
Financial Leverage Ratio
1.34 1.59 1.54 1.36 1.64
Debt Service Coverage Ratio
0.00 54.85 57.34 153.33 67.75
Interest Coverage Ratio
0.00 152.00 62.39 173.38 71.49
Debt to Market Cap
0.00 0.02 0.00 0.00 0.00
Interest Debt Per Share
0.05 0.09 0.06 0.04 0.06
Net Debt to EBITDA
-1.52 -1.08 -0.58 -1.24 -1.08
Profitability Margins
Gross Profit Margin
71.53%72.42%71.53%71.64%71.18%
EBIT Margin
28.65%30.79%25.40%31.85%24.87%
EBITDA Margin
29.76%35.58%29.19%35.09%30.25%
Operating Profit Margin
28.63%32.27%24.53%30.10%24.01%
Pretax Profit Margin
28.01%30.58%25.00%31.68%24.53%
Net Profit Margin
19.99%22.40%18.37%23.20%17.03%
Continuous Operations Profit Margin
19.99%22.31%17.77%22.18%16.50%
Net Income Per EBT
71.38%73.26%73.47%73.23%69.40%
EBT Per EBIT
97.82%94.78%101.95%105.23%102.19%
Return on Assets (ROA)
18.28%23.12%22.48%27.27%22.03%
Return on Equity (ROE)
26.50%36.87%34.62%37.09%36.12%
Return on Capital Employed (ROCE)
30.86%45.07%37.34%42.35%40.26%
Return on Invested Capital (ROIC)
21.50%31.56%26.49%30.36%26.96%
Return on Tangible Assets
18.44%23.33%22.81%27.69%22.54%
Earnings Yield
7.02%11.63%10.16%11.55%10.09%
Efficiency Ratios
Receivables Turnover
16.52 0.00 0.00 21.27 13.65
Payables Turnover
3.06 3.40 4.42 5.03 2.80
Inventory Turnover
3.22 5.05 5.59 6.41 4.88
Fixed Asset Turnover
11.69 13.75 13.17 21.54 13.78
Asset Turnover
0.91 1.03 1.22 1.18 1.29
Working Capital Turnover Ratio
1.96 2.50 2.19 2.18 3.23
Cash Conversion Cycle
16.10 -35.16 -17.30 1.61 -28.72
Days of Sales Outstanding
22.09 0.00 0.00 17.16 26.73
Days of Inventory Outstanding
113.43 72.28 65.29 56.98 74.86
Days of Payables Outstanding
119.42 107.44 82.59 72.53 130.31
Operating Cycle
135.52 72.28 65.29 74.14 101.59
Cash Flow Ratios
Operating Cash Flow Per Share
0.19 0.35 0.12 0.27 0.24
Free Cash Flow Per Share
0.19 0.34 0.10 0.27 0.24
CapEx Per Share
<0.01 <0.01 0.02 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.96 0.97 0.86 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
1.45 3.19 0.37 4.43 72.54
Capital Expenditure Coverage Ratio
23.39 36.75 7.36 323.46 72.54
Operating Cash Flow Coverage Ratio
3.81 4.15 2.17 7.26 3.95
Operating Cash Flow to Sales Ratio
0.30 0.42 0.14 0.28 0.26
Free Cash Flow Yield
10.01%20.98%6.47%13.93%15.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.25 8.60 9.84 8.66 9.91
Price-to-Sales (P/S) Ratio
2.85 1.93 1.81 2.01 1.69
Price-to-Book (P/B) Ratio
3.50 3.17 3.41 3.21 3.58
Price-to-Free Cash Flow (P/FCF) Ratio
9.99 4.77 15.44 7.18 6.46
Price-to-Operating Cash Flow Ratio
9.56 4.64 13.35 7.15 6.37
Price-to-Earnings Growth (PEG) Ratio
0.31 0.46 -0.36 0.23 -0.36
Price-to-Fair Value
3.50 3.17 3.41 3.21 3.58
Enterprise Value Multiple
8.05 4.34 5.61 4.49 4.50
Enterprise Value
93.27M 77.78M 85.88M 90.68M 75.01M
EV to EBITDA
8.05 4.34 5.61 4.49 4.50
EV to Sales
2.40 1.54 1.64 1.57 1.36
EV to Free Cash Flow
8.40 3.82 14.00 5.62 5.22
EV to Operating Cash Flow
8.04 3.71 12.10 5.61 5.14
Tangible Book Value Per Share
0.52 0.50 0.45 0.59 0.42
Shareholders’ Equity Per Share
0.53 0.51 0.46 0.60 0.43
Tax and Other Ratios
Effective Tax Rate
0.29 0.27 0.27 0.27 0.31
Revenue Per Share
0.65 0.84 0.87 0.96 0.92
Net Income Per Share
0.13 0.19 0.16 0.22 0.16
Tax Burden
0.71 0.73 0.73 0.73 0.69
Interest Burden
0.98 0.99 0.98 0.99 0.99
Research & Development to Revenue
0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
0.07 0.00 0.09 0.06 0.07
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.49 1.86 0.54 0.89 1.08
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis